Vera Therapeutics Inc - Class A (VERA) Stock Price

40.195 ▲ +2.095 (+5.50%)
Open: 39.24 Vol: 34.4K Day's range: 38.02 - 40.24 Mar 31, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VERA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 39.95▲ 39.57▲ 39.47▲ 39.52▲ 39.72▲
MA10 39.68▲ 39.34▲ 38.88▲ 39.83▲ 41.01▼
MA20 39.53▲ 38.84▲ 38.76▲ 39.88▲ 43.16▼
MA50 39.44▲ 39.14▲ 39.59▲ 42.08▼ 31.70▲
MA100 39.04▲ 39.70▲ 39.84▲ 41.61▼ 34.43▲
MA200 38.85▲ 39.90▲ 40.25▼ 33.13▲ 26.32▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.087▲ 0.164▲ 0.223▲ 0.074▲ -1.241▼
RSI 71.425▲ 64.234▲ 61.626▲ 48.652▼ 52.810▲
STOCH 93.552▲ 70.772     69.548     41.545     16.906▼
WILL %R -4.369▲ -2.009▲ -1.944▲ -48.563     -83.477▼
CCI 168.697▲ 135.757▲ 162.541▲ -40.599     -89.589    
Latest Filters Detected On VERA
▲ MACD $VERA MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $VERA Price Crossed Above MA(26) Set Alert
MA $VERA Price Crossed Above MA(13) Set Alert
MA $VERA Price Crossed Above MA(7) Set Alert
▲ GAP $VERA Open Gap Up %2 Set Alert
Vera Therapeutics Inc - Class A News
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
Wednesday, March 25, 2026 04:45 AM
Jane has worked with Vera Therapeutics previously as a strategic legal consultant and brings a depth and breadth of experience in supporting companies through regulatory approvals, commercialization, ...
Vera's FY25 Net Loss Widens; FDA To Decide On Atacicept In July
Thursday, February 26, 2026 01:00 PM
(RTTNews) - Vera Therapeutics Inc. (VERA), a late clinical-stage biotechnology company developing treatments for immunological diseases, has a couple of clinical trial catalysts and regulatory ...
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
Wednesday, January 07, 2026 04:30 AM
FDA assigned PDUFA target action date of July 7, 2026. If approved, atacicept would be the first B cell modulator targeting both BAFF and APRIL for IgAN. Atacicept received FDA Breakthrough Therapy ...
VERA historical stock data
date open high low close volume
31/03/26 39.24 40.27 38.02 40.195 1,602,069
30/03/26 38.98 39.05 37.90 38.10 401,618
27/03/26 39.22 40.47 38.165 38.86 733,263
26/03/26 39.46 40.98 39.26 40.26 625,785
25/03/26 40.38 41.55 39.83 40.16 1,391,551
24/03/26 39.84 40.15 38.235 39.75 905,877
23/03/26 41.55 42.25 39.495 40.73 1,459,654
20/03/26 41.18 42.21 40.14 40.53 3,982,254
19/03/26 37.60 41.48 37.51 41.37 1,574,952
18/03/26 39.12 39.12 38.12 38.32 593,032
Quote Details
52wk Low:18.53
52wk High:56.05
Vol:34.4K
Avg Vol(3m):22.8M
1Y Chng:+89.24%
1M Chng:-8.79%
Add to Watch List
More Information
Index US Composite
Market Cap. 2.77B